Study suggests screening of all newly diagnosed cancer patients for hepatitis
Screening patients with newly diagnosed cancer to identify hepatitis B virus and hepatitis C virus infection before starting treatment may be warranted to prevent viral reactivation and adverse clinical outcomes, says a study published online on Jan. 17, 2019 in JAMA Oncology. In this cohort study of 3051 patients with newly diagnosed cancer, infection rates were 6.5% for previous hepatitis B virus, 0.6% for chronic hepatitis B virus, 2.4% for hepatitis C virus, and 1.1% for HIV.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies